For the Inventor, By the Inventor

Enter inventor name

Jyderup, Denmark

John Bondo Hansen

USPTO Granted Patents = 40 (Patent Applications = 6)

CIPO Patents = 5 (Patent Applications = 8)

EPO Patents = 6 (Patent Applications = 11)

Average Co-Inventor Count = 3.1

ph-index = 8

Forward Citations = 215(Granted Patents)

Location History:

Lyngby, DK (1986 - 1994)
Jyderup, DK (1992 - 2020)
Copenhagen, DK (2020 - 2024)

Company Filing History:

17 out of 1,777

Novo Nordisk A/s

Schering Aktiengesellschaft

Contera Pharma Aps

Conrig Pharma Aps

Contera Pharma A/s

Novo Nordiskals

Novo Nordisk Ais

Novo Nordisk N/a

Solural Pharma Aps

11. 1 out of 832,843

Other

patents

where one patent can have more than one assignee

Years Active: 1986-2024

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

Pulsatile Drug Delivery

Suplatast Tosilate

Serotonin Receptor Agonists

Movement Disorders

Fused Thiadiazine Derivatives

Piperidine Derivatives

Indole Derivatives

CNS Disorders

Beta-Carboline Derivatives

Oxadiazolyl Imidazobenzodiazepine

Substituted Urea Compounds

Aza Spiro Decane

40 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11975104 - Pulsatile drug delivery system for treating morning akinesia (2024-05-07),

2. 11819482 - Composition comprising suplatast tosilate (2023-11-21),

3. 11690814 - Suplatast tosilate for use in the treatment of cough associated with interstitial lung disease (2023-07-04),

4. 11478476 - Use of buspirone metabolites (2022-10-25),

5. 10632116 - Combinations of serotonin receptor agonists for treatment of movement disorders (2020-04-28),

6. 10561618 - Orally available pharmaceutical formulation suitable for improved management of movement disorders (2020-02-18),

7. 9186359 - Combinations of serotonin receptor agonists for treatment of movement disorders (2015-11-17),

8. 6410743 - Tetrahydronaphtalene derivatives and their use (2002-06-25),

9. 6365609 - Substituted 3,3-diamino-2-propenenitriles, their preparation and use (2002-04-02),

10. 6362205 - Substituted 3,3-diamino-2-propenenitriles, their preparation and use (2002-03-26),

11. 6329367 - Fused 1,2,4-thiadiazine derivatives, their preparation and use (2001-12-11),

12. 6242443 - 1,2,4-benzothiadiazine derivatives, their preparation and use (2001-06-05),

13. 6232310 - Fused 1,4-thiazine-2-carbonitrile derivatives, their preparation and use (2001-05-15),

14. 6225310 - Fused 1,2,4-thiadiazine derivatives, their preparation and use (2001-05-01),

15. 6147098 - Substituted guanidines and diaminonitroethenes, their preparation and use (2000-11-14),

As an AI assistant specialized in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can provide you with an insightful article about inventor John Bondo Hansen and his remarkable contributions to the field of innovation.

Title: The Visionary Inventor: John Bondo Hansen

Introduction:

John Bondo Hansen, a renowned inventor based in Copenhagen, Denmark, has carved a niche for himself in the realm of innovation through his dedication, creativity, and pioneering spirit. His relentless pursuit of excellence has established him as a visionary in the world of technology, inspiring generations of innovators.

Latest Patents:

John Bondo Hansen holds a significant patent for a groundbreaking invention titled "Pulsatile drug delivery system for treating morning akinesia." This innovative pharmaceutical composition, developed for managing OFF-time episodes in patients with Parkinson's disease, showcases his profound understanding of medical needs and cutting-edge solutions.

Career Highlights:

Currently working at Contera Pharma A/S, John Bondo Hansen continues to push the boundaries of innovation within the pharmaceutical industry. His expertise in developing advanced drug delivery systems has garnered recognition and admiration from peers and industry professionals alike.

Collaborations:

Collaborating with esteemed colleagues such as Mikael Søndergård Thomsen and Ann Vivian Fullerton, John Bondo Hansen has fostered a dynamic work environment that thrives on innovation and collaboration. His ability to work seamlessly with experts in the field has led to the creation of groundbreaking technologies that impact lives positively.

Conclusion:

In conclusion, John Bondo Hansen's unwavering commitment to innovation, coupled with his visionary approach to problem-solving, exemplifies the essence of a true inventor. His trailblazing work serves as a beacon of inspiration for aspiring innovators and underscores the significance of continuous advancement in shaping the future of technology and healthcare.

For more fascinating insights into inventors, innovations, and patents, visit idiyas.com – your hub for all things innovative and inventive.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…